Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-22

Clinical Trial Update: A Study of Alendronate Sodium Vitamin D3 Tablets on Knee Osteoarthritis [Phase 4]

View source ↗

Summary

Phase 4 trial update for alendronate sodium vitamin D3 tablets in knee osteoarthritis; current status unavailable.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alendronate sodium vitamin D3 tablets (alendronate sodium + vitamin D3)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Knee Osteoarthritis | Phase 4 | Status: UNKNOWN